21 CFR Part 890 · Physical Medicine Devices

21 CFR 890.5500

Infrared lamp

21 CFR 890.5500 is the regulation titled “Infrared lamp” in 21 CFR Part 890, Physical Medicine Devices. Since 2021, 6 FDA warning letters have cited it.

Letters citing it
6 since 2021
Jan 1 to Oct 30, 2026
0 against 3 on the same dates in 2025
Most often cited with
21 CFR 807.81, in 6 letters
Closed out
33% of these letters have a published close-out
See the 6 letters citing 21 CFR 890.5500 →

Letters citing it, by year issued

Most are medical device letters (5 of 6). 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 12022
  3. 12023
  4. 12024
  5. 32025
  6. 02026

The regulation

Read the text of 21 CFR 890.5500 (eCFR, as of Sep 1, 2026)

(a) Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.

(b) Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

[48 FR 53047, Nov. 23, 1983, as amended at 84 FR 71818, Dec. 30, 2019]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 890.5500.

Latest letters citing it

The 3 letters citing 21 CFR 890.5500 that FDA posted most recently.

See the 6 letters citing 21 CFR 890.5500 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.